This is a demo store. No orders will be fulfilled.

Daxdilimab (anti-ILT7) - Primary antibody, specific to LILRA4, >95%, high purity, Human IgG1, INHIBITOR of Leukocyte immunoglobulin-like receptor subfamily A member 4 inhibitor, INHIBITOR of Leukocyte immunoglobulin-like receptor subfamily A member 4 inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Cynomolgus monkey,Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab170886
Grouped product items
SKU Size
Availability
Price Qty
Ab170886-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$66.90
Ab170886-1mg
1mg
5
$339.90
Ab170886-5mg
5mg
1
$869.90
Ab170886-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,389.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Daxdilimab (anti-ILT7) - Primary antibody, specific to LILRA4, >95%, high purity, Human IgG1, INHIBITOR of Leukocyte immunoglobulin-like receptor subfamily A member 4 inhibitor
Synonyms CD85 antigen-like family member G antibody | CD85g antibody | ILT-7 antibody | ILT7 antibody | Immunoglobulin like transcript 7 antibody | Immunoglobulin-like transcript 7 antibody | Leukocyte immunoglobulin-like receptor subfamily A member 4 antibody | L
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity LILRA4
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Leukocyte immunoglobulin-like receptor subfamily A member 4 inhibitor
Product Description

Daxdilimab (anti-ILT7) is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab (anti-ILT7) can be used in acute lung injury (ALI) in patients with COVID-19 infection research.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type lambdaC2
SDS-PAGE 29.5 kDa (Light Chain) & 51.9 kDa (Heavy Chain), under reducing conditions; 184.3 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2245966-28-1

Associated Targets(Human)

LILRA4 Tbio Leukocyte immunoglobulin-like receptor subfamily A member 4 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Daxdilimab (anti-ILT7) (Ab170886) - ELISA
Immobilized d hu-ILT7-ECD-His at 2 μg/mL can bind Daxdilimab (anti-ILT7) (Ab170886) with the EC₅₀ of 72.54 ng/mL.

Daxdilimab (anti-ILT7) (Ab170886) - SEC
The purity of Daxdilimab (anti-ILT7) (Ab170886) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot Number Certificate Type Date Item
ZJ23F1202081 Certificate of Analysis Dec 20, 2023 Ab170886
ZJ23F1202080 Certificate of Analysis Dec 20, 2023 Ab170886

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.